Evolving Technologic Strategies for Managing Juvenile Idiopathic Arthritis
Technological advances may assist children and adolescents with JIA, who are both more forgetful and more resistant to therapy.
Technological advances may assist children and adolescents with JIA, who are both more forgetful and more resistant to therapy.
The effect of rheumatic disease on vaccine safety in children was examined.
FENO monitoring may provide a biomarker of disease activity and signify the emergence of pulmonary involvement in kids with SLE.
Healthcare systems are expanding based on the number of people covered, and the care quality they receive.
Children are some of the most susceptible to Lyme disease. In many children, joint inflammation may be the first symptom.
Passage of the 2017 budget, along with congressional approval of the AHCA, leaves large holes in the funding of the proposed national approach to infectious disease control.
The UK National Osteoporosis Guideline Group released updated guidelines for the prevention of fragility fracture in postmenopausal women and in men aged 50 years or older.
A bill aimed specifically at limiting medical liability was passed by Congress on March 1, 2017.
Periodontal disease may be the main precipitating factor in the development of rheumatoid arthritis by fostering the environment for multiple destructive mechanisms that attack synovial joints.
Congress takes up the issue of antibiotic resistance with H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation (READI).